Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)

CAPS Rating: 4 out of 5

A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.

Recs

0
Player Avatar LevGross (37.11) Submitted: 5/28/2010 9:53:01 AM : Outperform Start Price: $28.19 RDY Score: -12.40

Really like this company. Major player in generics in the US and positioned in the country with the biggest growth potential. Buy this and ABB.

Featured Broker Partners


Advertisement